British Journal of Anaesthesia, 1988, Vol. 60, No. 2 228-231
© 1988 The Board of Management and Trustees of the British Journal of Anaesthesia
case-report |
MUSCLE RELAXATION IN PATIENTS WITH DUCHENNE'S MUSCULAR DYSTROPHY
Use of Vecuronium in Two Patients
University Department of Anaesthesiology, Joseph-Stelzmann-Str 9, D-5000 Koeln 41, Federal Republic of Germany
Cumulative 50% and 90% neuromuscular blocking doses of vecuronium were determined in two 4-yr-old boys with Duchenne's muscular dystrophy. Vecuronium 20 µg kg1 was required for 50% twitch depression in both patients. The 90% blocking doses were 43 and 57 µg kg1. Although these data do not indicate a greater than normal sensitivity to vecuronium, the recovery time (7525% block) of twitch tension was three to almost six times as long as in normal children. The evoked compound EMG, additionally recorded in one patient, reflected almost the same dose-response relationship as twitch tension, yet the EMG recovered faster than the twitch. The present findings do not exclude an increased sensitivity to neuromuscular blocking drugs in a larger population of patients with muscular dystrophy. Thus, the titration of the individual neuromuscular blocking dose with the aid of a nerve stimulator is mandatory. During a previous anaesthetic, cardiac arrest and acute rhabdomyolysis had occurred in one patient. The substitution of suxamethonium by vecuronium, or probably any other non-depolarizing myoneural blocking drug of intermediate or short duration of action, may help to avoid this complication.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Schmidt, T. Muenster, S. Wick, J. Forst, and H. J. Schmitt Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy Br. J. Anaesth., December 1, 2005; 95(6): 769 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Frankowski, J. O. Johnson, and J. D. Tobias Rapacuronium Administration to Two Children with Duchenne's Muscular Dystrophy Anesth. Analg., July 1, 2000; 91(1): 27 - 28. [Abstract] [Full Text] [PDF] |
||||

